Cannara Biotech (TSX:LOVE) Inventories, Work In Process: C$12.7 Mil (As of Feb. 2026)


TSX:LOVE Cannara Biotech Inc TSX:LOVE
92 GF Score
Price C$1.68
GF Value C$1.68
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Cannara Biotech Inventories, Work In Process?

Cannara Biotech TSX:LOVE +5.00% 92 Inventories, Work In Process is C$12.7 Mil as of Feb. 2026. GuruFocus rates TSX:LOVE with a GF Score™ of 92/100 and a GF Value™ of C$1.68 (Fairly Valued). The stock has 4 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Cannara Biotech's work in process for the quarter that ended in Feb. 2026 was C$12.7 Mil.

Cannara Biotech Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Cannara Biotech's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannara Biotech Inventories, Work In Process Chart

Cannara Biotech Annual Data
Trend Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Inventories, Work In Process
Get a 7-Day Free Trial 0.00 0.98 3.42 7.42 10.42

Cannara Biotech Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.69 8.85 10.42 11.44 12.70
TSX:LOVE
92GF Score
Cannara Biotech Inc TSX:LOVE
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cannara Biotech Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of C$12.7 Mil mean?
Cannara Biotech (TSX:LOVE) has a Inventories, Work In Process of C$12.7 Mil as of Feb. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Cannara Biotech and its competitors.
Is Cannara Biotech's Inventories, Work In Process too high?
Cannara Biotech's current Inventories, Work In Process is C$12.7 Mil. Overall, Cannara Biotech has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cannara Biotech's Inventories, Work In Process compare to ZTS?
Cannara Biotech's Inventories, Work In Process of C$12.7 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Drug Manufacturers company?
A good Inventories, Work In Process depends on the Drug Manufacturers industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Cannara Biotech and its competitors. Cannara Biotech's current Inventories, Work In Process is C$12.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannara Biotech stock overvalued right now?
Based on GuruFocus' analysis, Cannara Biotech (TSX:LOVE) is currently considered Fairly Valued. The stock's GF Value™ is C$1.68, compared to a current price of C$1.68 — trading right at its estimated fair value. The current Inventories, Work In Process is C$12.7 Mil. Cannara Biotech's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Cannara Biotech (TSX:LOVE), the current Inventories, Work In Process is C$12.7 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cannara Biotech (TSX:LOVE) Overvalued in 2026?

Based on GuruFocus' analysis, Cannara Biotech stock appears to be undervalued. The current stock price of C$1.68 is trading 0% below its estimated GF Value™ of C$1.68. GuruFocus considers Cannara Biotech to be Fairly Valued.

Key valuation signals for TSX:LOVE:

  • Inventories, Work In Process: C$12.7 Mil
  • GF Value™: C$1.68 vs. price of C$1.68 (0% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the TSX:LOVE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cannara Biotech Business Description

Other Exchanges LOVFF:USA8CB0:Germany
Address 1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3
Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .
92GF Score

Get the complete analysis for TSX:LOVE

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.68
Price
C$1.68
GF Value